Sosei Group Corp Files Patent for Azetidinylpyrimidin-2-Amine Derivatives as H4 Receptor Antagonists
According to GlobalData’s company profile on Sosei Group, was a key innovation area identified from patents. Sosei Group‘s grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
A recently filed patent (Publication Number: US20230167094A1) discloses a compound that has potential applications in the field of medicine. The patent claims include the compound itself, as well as its pharmaceutically acceptable salts. Additionally, the patent claims a pharmaceutical composition comprising the compound and a pharmaceutically acceptable excipient.
The compound described in the patent has H4 receptor activity and exhibits low hERG activity. This suggests that it may have therapeutic potential in the treatment of inflammatory disorders, including asthma, chronic pruritus, dermatitis, rheumatoid arthritis, gastric ulcerogenesis, and colitis. The patent specifically mentions the use of the compound or composition for the treatment of these inflammatory disorders.
The patent also claims the use of the compound or composition for medicinal purposes. This indicates that the compound may have broader applications beyond the treatment of inflammatory disorders.
Overall, this patent presents a compound with potential pharmaceutical applications in the treatment of inflammatory disorders. The compound’s specific properties, such as H4 receptor activity and low hERG activity, make it a promising candidate for further research and development in the field of medicine.
To know more about GlobalData’s detailed insights on Sosei Group, buy the report here.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
Source link
#Sosei #Group #Corp #Files #Patent #Azetidinylpyrimidin2Amine #Derivatives #Receptor #Antagonists
